Medication info

Sitagliptin tablets 100 mg (Sitagliptin Phosphate Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
Kukje Pharmaceutical Co., Ltd.
Appearance
Beige colored, round, double-sided convex film-coated tablets
Packaging
In-house packaging unit
Approval status
Expired

MFDS item code 201503241 · Approved 2015.05.28

This product's status changed to Expired on 2025.05.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This drug is administered at a dose of 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken without regard to meals. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function is recommended before starting this drug and periodically during treatment. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Kukje Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be administered as monotherapy, and in cases where blood sugar control is difficult with monotherapy despite no previous diabetes medication treatment, it can be used in combination with Metformin. Additionally, this medication is administered in combination if blood sugar control is insufficient with monotherapy of Sulfonylurea, Metformin, Thiazolidinedione, or insulin. When control of blood sugar is difficult even with combination therapy, this medication is added to the combination of Sulfonylurea, Metformin, Thiazolidinedione, or insulin to improve blood sugar control. It is a medication that effectively helps control blood sugar when used alongside various treatment methods.

How to take

Adult dose

This drug is administered at a dose of 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken without regard to meals. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function is recommended before starting this drug and periodically during treatment. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered without regard to the timing of dialysis.

Precautions

This medication may cause severe hypersensitivity reactions after administration, so if allergy symptoms are suspected, it should be discontinued immediately, and medical attention should be sought. During the use of this medication, attention should be paid to symptoms of acute pancreatitis, and if pancreatitis is suspected, discontinue the medication and consult healthcare personnel immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Patients who have had allergic reactions to this medication or its components should not take it. Patients with impaired kidney function need to adjust the dosage of this medication, and periodic kidney function tests are important. There is a risk of hypoglycemia when taking this medication, especially when taken with insulin or Sulfonylurea, so blood sugar should be carefully monitored, and dosage adjustments may be necessary. Severe joint pain or bullous skin disorders may occur, so if these symptoms appear, consult a doctor immediately. Pregnant or nursing women are advised to avoid taking this medication, and safety and efficacy have not been confirmed in children and adolescents under 18 years of age. Elderly patients may be at risk of impaired kidney function, so dosage adjustments and kidney function monitoring are necessary. In case of overdose, general emergency treatment should be carried out, and if necessary, some medications may be removed via hemodialysis. This medication has relatively few interactions when combined with other diabetes medications or certain drugs, but caution is needed when used with specific medications. If unusual symptoms or discomfort occur while taking the medication, consult healthcare personnel immediately.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory infection
  • headache
  • diarrhea
  • abdominal pain
Show 28 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid-like eruption
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air from entering and kept at a temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Beige colored, round, double-sided convex film-coated tablets

Package unit

In-house packaging unit

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.